Investigation of Filaggrin Gene Mutations Among Latinx Patients With Atopic Dermatitis

Bronchial Hyperreactivity in Atopic Dermatitis Patients - a 10 Year Follow-up

NCT00795496 ·Status: COMPLETED

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

NCT07003425 ·Status: RECRUITING ·Phase: PHASE2

Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis

NCT04804605 ·Status: COMPLETED ·Phase: PHASE3

Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.

NCT05265234 ·Status: UNKNOWN ·Phase: PHASE4

Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation

NCT05098821 ·Status: RECRUITING

Targeting Staphylococci in Atopic Dermatitis

NCT05502185 ·Status: UNKNOWN

Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic Dermatitis

NCT06998056 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis

NCT03915496 ·Status: COMPLETED ·Phase: PHASE2

A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis

NCT05571943 ·Status: COMPLETED ·Phase: PHASE3

Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis

NCT03293030 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis

NCT04668066 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema

NCT04378569 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

NCT07290803 ·Status: RECRUITING

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

NCT07105488 ·Status: RECRUITING ·Phase: PHASE2

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

NCT00605878 ·Status: RECRUITING

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

NCT06807281 ·Status: RECRUITING ·Phase: PHASE3

Targeted Microbiome Transplant in Atopic Dermatitis

NCT03151148 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

NCT03422822 ·Status: COMPLETED ·Phase: PHASE3

Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic Dermatitis

NCT02369432 ·Status: TERMINATED ·Phase: EARLY_PHASE1

A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema

NCT05259722 ·Status: COMPLETED ·Phase: PHASE3

Investigating Immune Mechanisms in Atopic Eczema

NCT02102841 ·Status: WITHDRAWN ·Phase: NA

A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM)

NCT00746382 ·Status: WITHDRAWN ·Phase: PHASE2

Study of Apremilast in Atopic or Contact Dermatitis

NCT00931242 ·Status: COMPLETED ·Phase: PHASE2

Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT06585202 ·Status: COMPLETED ·Phase: PHASE2

Dupilumab in Severe Chronic Hand Eczema

NCT04512339 ·Status: UNKNOWN ·Phase: PHASE2